The protective effects of dexmedetomidine on the liver and remote organs against hepatic ischemia reperfusion injury in rats

International Journal of Surgery

Volumn 11, Issue 1, 2013, Pages 96-100

  Tüfek, Adnan ^a   Tokgöz, Orhan ^a   Aliosmanoglu, Ibrahim ^a   Alabalik, Ulaş ^a   Evliyaoglu, Osman ^a   Çiftçi, Taner ^a   Güzel, Abdülmenap ^a   Yildirim, Zeynep Baysal ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Dexmedetomidine; Hepatic ischemia reperfusion injury; Rat

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; DEXMEDETOMIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY PARENCHYMA; LIVER HISTOLOGY; LIVER ISCHEMIA; LIVER PROTECTION; LUNG PARENCHYMA; MALE; NONHUMAN; OXIDATIVE STRESS; PRINGLE MANEUVER; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; TOTAL ANTIOXIDANT CAPACITY; TOTAL OXIDANT ACTIVITY;

ANIMALS; ARYLDIALKYLPHOSPHATASE; DEXMEDETOMIDINE; HISTOCYTOCHEMISTRY; KIDNEY; LIVER; LUNG; MALE; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; STATISTICS, NONPARAMETRIC;

EID: 84872615115     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2012.12.003     Document Type: Article

References (38)

1. Kapan M., Gumus M., Onder A., Firat U., Basarali M.K., Boyuk A., et al. The effects of ellagic acid on the liver and remote organs' oxidative stress and structure after hepatic ischemia reperfusion injury caused by pringle maneuver in rats. Bratisl Lek Listy 2012, 113(5):274-281.
2. Zimmerman B.J., Granger D.N. Reperfusion injury. Surg Clin North Am 1992 Feb, 72(1):65-83.
3. Parks D.A., Granger D.N. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 1986 Jun, 250(6 Pt 1):G749-G753.
4. Grace P.A. Ischaemia-reperfusion injury. Br J Surg 1994 May, 81(5):637-647.
5. Hanci V., Erol B., Bektas S., Mungan G., Yurtlu S., Tokgoz H., et al. Effect of dexmedetomidine on testicular torsion/detorsion damage in rats. Urol Int 2010, 84(1):105-111.
6. Kocoglu H., Ozturk H., Yilmaz F., Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail 2009, 31(1):70-74.
7. Zhang X.Y., Liu Z.M., Wen S.H., Li Y.S., Li Y., Yao X., et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats. Anesthesiology 2012 May, 116(5):1035-1046.
8. Gertler R., Brown H.C., Mitchell D.H., Silvius E.N. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent) 2001 Jan, 14(1):13-21.
9. Uzar E., Alp H., Cevik M.U., Firat U., Evliyaoglu O., Tufek A., et al. Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol Sci 2012 Jun, 33(3):567-574.
10. Yuan G.J., Ma J.C., Gong Z.J., Sun X.M., Zheng S.H., Li X. Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/reperfusion injury in rats. World J Gastroenterol 2005 Mar 28, 11(12):1825-1828.
11. Teoh N.C., Farrell G.C. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003 Aug, 18(8):891-902.
12. Eckerson H.W., Wyte C.M., La Du B.N. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983 Nov, 35(6):1126-1138.
13. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004 Feb, 37(2):112-119.
14. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005 Dec, 38(12):1103-1111.
15. Camargo C.A., Madden J.F., Gao W., Selvan R.S., Clavien P.A. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997 Dec, 26(6):1513-1520.
16. Chatterjee P.K., Cuzzocrea S., Brown P.A., Zacharowski K., Stewart K.N., Mota-Filipe H., et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 2000 Aug, 58(2):658-673.
17. Ozdulger A., Cinel I., Koksel O., Cinel L., Avlan D., Unlu A., et al. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 2003 Apr, 19(4):366-372.
18. Sehirli O., Ozel Y., Dulundu E., Topaloglu U., Ercan F., Sener G. Grape seed extract treatment reduces hepatic ischemia-reperfusion injury in rats. Phytother Res 2008 Jan, 22(1):43-48.
19. Arab H.A., Sasani F., Rafiee M.H., Fatemi A., Javaheri A. Histological and biochemical alterations in early-stage lobar ischemia-reperfusion in rat liver. World J Gastroenterol 2009 Apr 28, 15(16):1951-1957.
20. Kharbanda R.K., Peters M., Walton B., Kattenhorn M., Mullen M., Klein N., et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001 Mar 27, 103(12):1624-1630.
21. Inci F.D.I., Eti Z. The effects of dexmedetomidine infusion on the formation of reactive oxygen species during mesenteric ischemia-reperfusion injury in rats. Marmara Med J 2007, 20(3):154-160.
22. Kaplan N., Yagmurdur H., Kilinc K., Baltaci B., Tezel S. The protective effects of intravenous anesthetics and verapamil in gut ischemia/reperfusion-induced liver injury. Anesth Analg 2007 Nov, 105(5):1371-1378. [Table of contents].
23. Topsakal C., Kilic N., Ozveren F., Akdemir I., Kaplan M., Tiftikci M., et al. Effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury. Spine (Phila Pa 1976) 2003 Aug 1, 28(15):1643-1652.
24. Ozturk E., Balat O., Acilmis Y.G., Ozcan C., Pence S., Erel O. Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method. J Obstet Gynaecol Res 2011 Apr, 37(4):337-342.
25. Uzar E., Acar A., Evliyaoglu O., Firat U., Kamasak K., Gocmez C., et al. The anti-oxidant and anti-apoptotic effects of nebivolol and zofenopril in a model of cerebral ischemia/reperfusion in rats. Prog Neuropsychopharmacol Biol Psychiatry 2012 Jan 10, 36(1):22-28.
26. Kandis H., Karapolat S., Yildirim U., Saritas A., Gezer S., Memisogullari R. Effects of Urtica dioica on hepatic ischemia-reperfusion injury in rats. Clinics (Sao Paulo) 2010, 65(12):1357-1361.
27. Sozen S., Kisakurek M., Yildiz F., Gonultas M., Dincel A.S. The effects of glutamine on hepatic ischemia reperfusion injury in rats. Hippokratia 2011 Apr, 15(2):161-166.
28. Arslan M., Metin Comu F., Kucuk A., Ozturk L., Yaylak F. Dexmedetomidine protects against lipid peroxidation and erythrocyte deformability alterations in experimental hepatic ischemia reperfusion injury. Libyan J Med 2012, 7.
29. Lv X., Wang Z.M., Huang S.D., Song S.H., Wu F.X., Yu W.F. Emulsified isoflurane preconditioning reduces lung injury induced by hepatic ischemia/reperfusion in rats. Int J Med Sci 2011, 8(5):353-361.
30. Zhou L., Yao X., Chen Y. Dexamethasone pretreatment attenuates lung and kidney injury in cholestatic rats induced by hepatic ischemia/reperfusion. Inflammation 2012 Feb, 35(1):289-296.
31. Can M., Gul S., Bektas S., Hanci V., Acikgoz S. Effects of dexmedetomidine or methylprednisolone on inflammatory responses in spinal cord injury. Acta Anaesthesiol Scand 2009 Sep, 53(8):1068-1072.
32. Engelhard K., Werner C., Eberspacher E., Bachl M., Blobner M., Hildt E., et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003 Feb, 96(2):524-531. [Table of contents].
33. Yagmurdur H., Ozcan N., Dokumaci F., Kilinc K., Yilmaz F., Basar H. Dexmedetomidine reduces the ischemia-reperfusion injury markers during upper extremity surgery with tourniquet. J Hand Surg Am 2008 Jul-Aug, 33(6):941-947.
34. Gul S., Hanci V., Bahadir B., Acikgoz S., Bektas S., Ankarali H., et al. The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats. J Clin Neurosci 2010 Apr, 17(4):490-494.
35. Eser O., Fidan H., Sahin O., Cosar M., Yaman M., Mollaoglu H., et al. The influence of dexmedetomidine on ischemic rat hippocampus. Brain Res 2008 Jul 7, 1218:250-256.
36. Wittner M., Sivenius J., Koistinaho J. Alpha2-adrenoreceptor agonist, dexmedetomidine, alters acute gene expression after global ischemia in gerbils. Neurosci Lett 1997 Aug 29, 232(2):75-78.
37. Okada H., Kurita T., Mochizuki T., Morita K., Sato S. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts. Resuscitation 2007 Sep, 74(3):538-545.
38. Yoshitomi O., Cho S., Hara T., Shibata I., Maekawa T., Ureshino H., et al. Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs. Shock 2012 Jul, 38(1):92-97.